Lloyds directors briefing and Solvency II update - looking well

With Solvency II news and comment pretty thin on the ground this month as the guys at EIOPA count their LTGA beans, it was nice to see the trailblazers at Lloyds release their director briefing slides from last week, an event one may assume is relatively frosty after the money spent in preparation and the distinctly agitated tone on the matter from their CEO recently!

Bling - things Lloyds could have
bought with £300m

As Lloyds are already well down the road of internal model development (having almost kept to their original IMAP deadline they were able to get materials down to the FSA prior to the implementation deadline shifting), the slides are very revealing as to where the group remain lacking when attempting to meet the Tests and Standards for Internal Model approval (TSIMs). With 84% of the market 'by materiality' meeting the principles of the TSIMs, they are clearly in good nick, although by stressing 'materiality', it implies that a relatively large number of smaller members are perhaps still lagging.

The list of "common issues" found will neither surprise nor delight anyone else in IMAP, given that the same themes have been festering for a good 18 months now, and the legislative paralysis on the continent has clearly done nothing to aid the industry (in particular, the FSA letter from this time last year touches on most of these!). Specifically, they observe problems in the following areas;

• ORSA - looking far enough forward (i.e. past year 1), and using stress and scenario testing effectively
• Validation - evidencing validation work done, and following up on test failures
• Model Change - justifying the thresholds for minor/major changes, and agreeing an approach for aggregating minor changes so that they can be considered as minor/major in aggregate
• Use Test - using the model for something other than spewing out an SCR, and it would appear also that when interviewed, the effectiveness of board training and their understanding of the model is being found wanting
• Documentation - documents are either not checking off against the TSIMs, or the content is contrary to the revised controls and processes which have been developed for Solvency II

As Julian Adams made clear at the turn of the year, full compliance with TSIMs is not part of the ICAS+ agenda down at the PRA, however they will expect firms to be fully aware of where they are currently light, and what they plan to do about it. Certainly looks like the Lloyds application won't struggle in this regard, and I wish them well.

FSA and ICA+ - making the best of a bad hand...

The FSA released the letter we've all been waiting for at the end of last week regarding their plans for  allowing UK firms to use their intended Solvency II-ready internal models to calculate their compulsory Individual Capital Assessments between now and the go-live date of Solvency II (don't laugh, it's still possible that it might go live ;-) )

I suspect a mix of suitability, financial necessity and pragmatism has led the regulator to pursue a relatively relaxed take on ICA+ , for example;

• It is "not a condition for IMAP review or approval"
• It "does not require Solvency II tests and standards [for internal model approval] to be met"
• Firms will confirm the scope of material which needs to be reviewed for ICA+ assessment, rather than the FSA themselves
• They also confirm that it is "not [their] intention" to bring in Solvency II reporting requirements "...any sooner than required by EIOPA"

That said, while the FSA try to thin out the field by noting that ICA+ is "most appropriate" for firms who are both in IMAP and due for a business-as-usual ICA review in the next two years, it would make sense for anyone in IMAP to pursue ICA+, more than anything because of the interminable delays in Europe might put a firm outside of ICA+ at a competitive disadvantage on the capital front.

The onus therefore appears to be on the industry to quantify and explain the differences between the inputs, processes and outputs of their ICA models and Solvency II models, as well as demonstrate how their ORSA processes address the existing requirements of INSPRU, specifically targeting INSPRU 7. There is also a sneaky request for a self-assessment of progress towards achieving compliance with the Solvency II tests and standards for internal model approval.

From a practitioner's perspective, I had a particularly large chortle at the requirement for all materials being used in the ICA+ assessment to have been approved by the firm's Board - I'm sure they are looking forward to another two years of swollen board packs...

There is more information to follow from the FSA in Q2 of this year, presumably on the basis that the  LTG assessment activity they are on the hook for will have concluded, and more focus can be shifted to this pioneering work. Congratulations to them for not overegging this particular pudding, on paper at least.

EIOPA, Parliament, IRSG and LTGs - momentum sustained?

I guess I should start with a Blein Vie Noa to one and all - after a relaxing few weeks in France I am now back on the beautiful Isle of Man sizing up opportunities for 2013 and beyond.

I didn't expect I would be missing much over the festive period and, other than the FSA sacking-off their proposed January IMAP industry briefing in favour of a (yet to be delivered) letter, things did go quiet. Freshfields kindly filled some airtime by pulling together another of their "where are we now" summaries that remain excellent (and free) materials that I would recommend punting on to your non-executive directors.

Luckily the noisemakers got back in the game as soon as school restarted, focused largely on the content of EIOPA's Insurance and Reinsurance Stakeholder Group's minutes. This meeting was held in October, so in terms of new news, it is right up there with "Earth is not flat". That said, we don't all have access to the inside track before publication of such materials, so it was interesting to pick through the doc for steers. I noted the following;

• Continuing problems with terms of reference for the LTG assessment (indeed the LTG sub-group note on p7 that there isn't even a EU-consistent definition for LTG!) - still looking like it will impact on the designated Plenary session for Omnibus II due to a combination of last minute delivery of the technical specifications to the industry itself as well as the output report to the Parliament, who themselves were reported today as being less than impressed with the final TORs. The potential number of scenarios in the assessment also clearly remains a sore point.
• Acknowledgement that "Autumn 2013" is now "best case scenario" for Omnibus II adoption, though, according to van Hulle at the last EIOPC meeting, the Commission and Parliament remain almost diametrically opposed on what should materialise at Level 1 and Level 2 (full minutes from EIOPC here)
• Confirms the ex-ante approach is favoured by Parliament and Commission (significance covered by Gideon here), and that Parliament have no wish to commit to an implementation timescale.
• The Council members are being "heavily lobbied", fostering implementation uncertainty.
• Attending stakeholders supported a definitive 2016 date.
• The IRSG's Governance sub-group flag up consistency issues around Fit and Proper regs as well as the "AMSB" term that I'm sure we have all had practical issues with over the last 2 years!
• Proportionality remains a "main concern" for mutuals, as well as smaller insurers - despite having a designated sub-group, any substantive guidance on applying the proportionality principle looks a distant prospect at best.
• Astonishingly, minutes from May 2012 could not be approved due to EIOPA's "workload" - small instance of an institutional tardiness problem?

Whether or not the industry is losing it's appetite for the Solvency II banquet, when you check out EIOPA's workplans for the next couple of years, at least one body will be filling its face!

Another interesting piece came out in the last week, when InsuranceERM pushed out the findings of a Solvency II roundtable (no sub required), bringing in a few UK-based CROs and the like, ostensibly to chew over the loss of momentum in the project. A few noteworthy bits jumped out;

• Solvency II balance sheet appears to be off the agenda for ICA+, for both regulator and industry
• Perception that, with the transition of regulatory "ownership" to the Bank of England, there is a decreased likelihood that the industry will be able to use Solvency II as a capital release mechanism
• A suggestion that the FSA was more minded towards EIOPA's opinions than the industry's during IMAP 1.0, something which has seemingly reversed with the advent of ICA+

One certainly hopes that the UK industry and regulator can make a decent fist of this indeterminate transition period without having to break the bank...

Legal and General - Counting the cost of Solvency II

Spotted by his Lordship John Walton this morning, L&G  appear to have broken the mould by dropping some substantive Solvency II comment into their Q3 IMS, notably that they have booked £129m of costs in project spend.

They also go on to plead unhappiness on the inability of the rules as they stand to encourage the provision of long-term capital to the wider economy, echoing DG Faull's rollocking letter to Sr Bernadino the other week on longer-duration debt instrument capital costs, though are clearly only interested in UK investment opportunities as opposed to loading up on fruity Eurozone government debt (good on you!).

Of course the Solvency II preparation costs of most of the big-boys have been covered on this blog before, and £129m feels suitably light for a UK-focused business in comparison to some of its more complicated competitors. That said, with the FSA offering some hope of a transition to "ICA+" rather than dual running ICA and IM SCR for the next x years, how much leverage does this sort of investment buy a firm down at Canary Wharf when it comes to meeting the transitional criteria?

Look forward to seeing a bit more of these disclosures over the next week or so now we are in IMS season, but not counting on it!

FSA's Adams on Solvency II delay, IMAP and ICA - how long do you want lads?

It would appear that stabs in the dark on the Solvency II implementation date by senior insurance industry officials are like British buses - after the omerta-like silence of September, no fewer than three bigwigs have piped up in the last few days. First Sr. Bernadino decided to do his briefing via a Stateside publication, settling on 2016 as most probable, followed by Sr Montalvo who concurred (along with a great joke about his missus!).

While it didn't take a handsome Archaeology graduate to know that 2014 was ash, what the industry likes more than anything is cold, hard confirmation from their friendly national supervisor...

...which came today! Julian Adams gave a speech this morning ostensibly about the practical side of implementing the PRA's new approach after they get divorced from their FCA counterparts next year. Worth bulleting the big messages on IMAP;

• Current timetable "completely unrealistic" after Plenary postponement confirmed last week
• 2015 "...likely to prove very challenging"
• FSA will agree a revised landing slot with IMAP participants (presumably just those who have yet to submit?), UP TO A MAXIMUM OF END DECEMBER 2015.
• Will change this to match up with what comes out of Brussels if the two are divergent
• For ICAS, "we will have to live with the current regime for longer than any of us expected"
• The previously stated "aspiration" of potentially replacing ICA with internal model SCR will be formalised into a two step process. First, reconcile ICA with IM SCR (the easy bit!), then once the FSA are sufficiently happy, just produce IM SCR.
• Retain discretion to apply ICG throughout the interim period
• Benefits of this approach will therefore include much meatier pre-application evidence of use.

Hard to know where to go with this. Great news for anyone who remains on target for their original landing slots, as there is potentially some early-adopter capital benefits if they can abandon ICA. That said, the recent E&Y industry survey (which I will look at separately) suggested the Brits are mostly in a good spot for IMAP, so does extending the window negatively impact on the work already delivered? Certainly opens up a rather pricey Pandora's box around Validation activity which I'm sure many firms would have been delighted to have paid for one-time-only!

All in all, these public declarations will be welcomed by everyone who isn't writing a cheque for next year's IMAP activity...

Omnibus II and the inevitable delay - why it's not so clear cut

Fantastic work over on the Solvency II Wire from Gideon on the meat and potatoes inside the eternally-baking Omnibus II pie, illustrating why the trialogue parties haven't just rolled over and declared 2015 as the new 2014.

While it would appear that the lobbying arms at Insurance Europe, AMICE, GCAE etc haven't piped up on industry preference yet, it looks like we have two deeply unpleasant alternatives to look forward to; hard launching a year late (i.e Omnibus II would only get signed off after the recently requested LTG consultation but 2015 would be the definitive "go-live"), or soft launching with 2 years parallel running (i.e. Omnibus II can go through before the LTG consult is finished, but with the sword of Damocles hanging over its contibution to the regulations until 2016).

My guess would be that there is little appetite in the firms for parallel running Solvency I/Solvency II to 2016 based on the administrative burdens this would currently place on the UK in particular through the current ICA process. A 'hard' 2015 and some more effective leadership in Brussels would be welcome relief to Solvency II Programmes from a planning perspective, though the knock-on effect on the model approval process and other scheduled supervisory work is yet to be seen.

Oddly, the EIOP-ians of the world pushed out the 2013 Work Programme this week which of course skips over any of the practicalities around such a delay - so having "already achieved a great deal" in Solvency II prep, they will "finalise the [53] standards and guidelines" currently required of them, set up an "internal model support expert unit", and "finalise the preparation of the [supervisory] Colleges" - and all of this while Rome burns!

It is a perverse situation when a subject as politically divisive as capital requirements for long term guarantees across the union is not as complex as trying to get three well-briefed parties around a table to agree on an implementation date. At a time when the Commission wants an inflation-busting funding rise (which Parliament have 'ole'd through) and EIOPA have grown in headcount and cost by 50% y-o-y, the alarming regularity with which national self-interest and horse-trading has derailed a project of such significance makes me long for the jingoistic certainty of the Corn Laws - I'm guessing that's not a good thing...

Lloyds of London on Solvency II - Annual Report content

Hot on the heels of their delay in submitting their IMAP pack to the FSA, Lloyds of London pushed out their annual report today - as ever, a riveting read in general (and emphasises the scale of Nat Cat activity last year), but I concentrated more on the Solvency II side. They noted;

• "… we have made excellent progress to ensure that, whatever its final implementation date, the Lloyd’s market will be operating to the standards required of Solvency II by January 2013" (p8) - no mention of the IMAP delay, although this could of course work in their favour when looking to achieve this target.
• "Lloyd’s preparations for Solvency II advanced well in 2011, both within the Corporation and the market, and the entire programme across all relevant parts of the business is on track" (p22) - again, odd when IMAP activity has been postponed 3 months!
• "...Solvency II may have a positive impact on the reinsurance sector by increasing demand for reinsurance products" (p49) - same message put out by Swiss Re.

They also note good progress on the ORSA process and reporting front;

• "Lloyd’s has also further developed its approach to the Own Risk and Solvency Assessment (ORSA) – which aligns all of the activities Lloyd’s uses to manage risks and ensure the right level and type of capital. This alignment improves the quality of management information and the resulting decisions. In 2011, we produced a series of pilot reports to enable senior management to review the ORSA’s proposed structure and content. A live report was finalised and approved by the Franchise Board during the first quarter of 2012. In future, the report will be produced at least annually." (p30)

And finally a nice piece of disclosure on economic capital;

• "The capital provided by every member is assessed according to the Lloyd’s Individual Capital Assessment (ICA) capital setting framework. When agreed, each ICA is then ‘uplifted’ (by 35% for 2011) to provide an extra buffer to support Lloyd’s rating and financial strength. This uplifted ICA, which is the Economic Capital Assessment (ECA), is used to determine members’ capital requirements subject to prescribed minimum levels. The FSA oversees the annual review of syndicate ICAs by the Corporation, which reviews the historical performance, business plans and risk appetite of that syndicate in assessing the adequacy of the capital level proposed." (p69).

Whether all of this is good enough to allow them to achieve their objective of avoiding parallel running ICA and the internal model in 2013 is anyone's guess, but let's wish them good luck.  

ABI Conference - FSA's Adams speaks on Internal Model Applications

The FSA have just published Julian Adams' speech on Internal Models from yesterday at the ABI Conference.

Worth noting;

On the potential to replace ICA with SCR for 2013 (which Lloyds et al have been lobbying hard on);

“What we are in a position to do, however, is to invite firms to consider how they think their work on their Solvency II model could be used to meet those current rules, thereby removing the need for parallel running of two different models”

“As the current requirements will remain in force, it will be incumbent on firms to satisfy themselves that the Solvency II model, alongside their wider system of risk management and governance, meets the existing requirements in our Handbook. By approaching the issue in this way, we intend to avoid the need for firms to apply for a complicated series of waivers or to seek specific permission from us to make the transition early. We believe this is both proportionate and appropriate, given the amount of review work we will have done with firms following submission of their Solvency II model application to us”

On the basis to be used for internal model applications (the original guidance, or EIOPA's L2 on Tests and Standards for internal model approval)

“It is clear that the Level 2 text – and, in due course, the Level 3 text which will supplement it – is more appropriate to use as a matter of principle, since this sets out much more clearly the basis on which we are expected to assess firms’ applications, and it is the standard against which you and we will ultimately be judged”

“On balance, we feel that basing our application approach on the Level 2 text is the most sensible way to proceed, and we propose to do this is by cross-referencing the Level 2 text in the guidance materials we will be making available to firms in February of next year”

“I am aware that this will mean that some firms may feel that their efforts in following the Contents of Application approach will have been wasted, and I would like to reassure you that this is not the case. We will expect you to submit documentary evidence that you meet the requirements set out in the Directive, and completion of the Contents of Application is likely to go a long way towards demonstrating compliance with the Level 2 requirements, but it is those Level 2 requirements which will be definitive”

Looks like anyone who is going to get pre-approval to use their model to meet existing FSA handbook requirements is going to have to jump through a lot of hoops, and even then may fall short

ABI, Lloyds & the FSA - behind closed doors...

Flagged elsewhere on Friday, I read through the FSA committee minutes which noted that “contingency” may be required (p3) if Solvency II is not implemented by 2013 – no mention of what that will consist of, though it sounds ominous and probably ends with the words “-million pounds”.

Also reported on Friday, the ABI and Lloyds are looking to lobby for a 2013 go-live date, regardless of the content of Omnibus II, so that Lloyds’ existing ICA process can be jettisoned and replaced by Internal Model SCR (thus restricting the dual ICA/SCR obligations to one year). I suspect they will have plenty of people who would ride on their coat-tails if they can squeeze this one through!